Citadel Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Sell |
|
|||||
|
2025
Q1 | $39.9M | Buy |
|
|||||
|
2024
Q4 | $59.8M | Buy |
|
|||||
|
2024
Q3 | $93.2M | Buy |
|
|||||
|
2024
Q2 | $24.7M | Sell |
|
|||||
|
2024
Q1 | $73.9M | Buy |
|
|||||
|
2023
Q4 | $1.33M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.45M | Sell |
|
|||||
|
2023
Q1 | $2.48M | Buy |
|
|||||
|
2022
Q4 | $225K | Sell |
|
|||||
|
2022
Q3 | $143K | Sell |
|
|||||
|
2022
Q2 | $347K | Sell |
|
|||||
|
2022
Q1 | $1.83M | Buy |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|
|||||
|
2021
Q3 | $779K | Sell |
|
|||||
|
2021
Q2 | $1.1M | Buy |
|
|||||
|
2021
Q1 | $454K | Sell |
|
|||||
|
2020
Q4 | $1.49M | Buy |
|
|||||
|
2020
Q3 | $763K | Buy |
|
|||||
|
2020
Q2 | $655K | Buy |
|
|||||
|
2020
Q1 | $99K | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $308K | Sell |
|
|||||
|
2019
Q1 | $10.7M | Buy |
|
|||||
|
2018
Q4 | $7.63M | Buy |
|
|||||
|
2018
Q3 | $16.5M | Buy |
|
|||||
|
2018
Q2 | $4.21M | Buy |
|
|||||
|
2018
Q1 | $65K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $108K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2016
Q1 | $19K | Buy |
|